You are here: Industry Insights > COVID-19

News List

Fulcrum to Evaluate Losmapimod as Potential COVID-19 Treatment americanpharmaceuticalreview
June 19, 2020
Fulcrum Therapeutics has announced plans to evaluate losmapimod as a potential treatment for patients with COVID-19.
Generic remdesivir may put pricing pressure on Indian pharma, says analyst europeanpharmaceuticalreview
June 19, 2020
According to an expert, Indian pharmaceutical companies will have to price remdesivir cautiously to ward off generic competition in the near future.
SFX‐01 to enter Phase II/III trials to test efficacy against COVID-19 symptoms europeanpharmaceuticalreview
June 19, 2020
The drug candidate SFX-01 is set to be studied in Phase II/III trials to test its efficacy at treating acute respiratory distress syndrome (ARDS), a complication of COVID‐19.
Tonix and Southern Research to study immune responses to Covid-19 pharmaceutical-technology
June 19, 2020
Tonix Pharmaceuticals has expanded its ongoing partnership with non-profit Southern Research to study T-cell immune responses to SARS-CoV-2, the novel coronavirus that causes Covid-19.
Optima Supports Catalent with High-Speed Vial Filling Line contractpharma
June 19, 2020
Prepares for large-scale commercial manufacturing of a lead vaccine candidate for COVID-19.
FDA Issues EUA to HymonSARS-CoV-2 Test Kit for Detection of COVID-19 contractpharma
June 19, 2020
SpectronRx and HymonBio expect to produce 10 million tests per month for labs around the world.
Study reveals COVID-19 virus can cause collapse of respiratory centre in brain expresspharma
June 19, 2020
May infect PreB?tzinger complex (PBC), primary centre of the brain that controls respiratory rhythm generation.
Bangladesh launches clinical trial of two-drug combination to treat COVID-19 expresspharma
June 19, 2020
Reportedly, the combination of anti-parasitic medicine Ivermectin and antibiotic doxycycline cured all the 60 COVID-19 patients within days.
Optimus launches COVID-19 drug Favipiravir, commences commercial export expresspharma
June 19, 2020
The drug is being marketed under the brand name Favicovid both in India and other countries.
Strategic short term measures needed on the API front: Pharma experts expresspharma
June 19, 2020
Experts feel that a multi-pronged strategy comprising both, short term and long term measures, are crucial to deal with the fall out of the COVID-19 pandemic as well as mounting friction between India and China.